Zeeneldin A, Al-Dhaibani N, Saleh Y, Ismail A, Alzibair Z, Moona M
Case Rep Oncol Med. 2019; 2018:9246139.
PMID: 30693122
PMC: 6332972.
DOI: 10.1155/2018/9246139.
Gwak H, Lee S, Park W, Shin S, Yoo H, Lee S
J Korean Neurosurg Soc. 2015; 58(1):1-8.
PMID: 26279806
PMC: 4534733.
DOI: 10.3340/jkns.2015.58.1.1.
Grewal J, Saria M, Grewal H, Kesari S
Clin Investig (Lond). 2012; 1(10):1391-1402.
PMID: 22396850
PMC: 3292801.
DOI: 10.4155/cli.11.115.
Chamberlain M
Curr Neurol Neurosci Rep. 2008; 8(3):249-58.
PMID: 18541120
DOI: 10.1007/s11910-008-0038-6.
Jacob E, Scorsone K, Blaney S, DArgenio D, Berg S
Pediatr Blood Cancer. 2007; 50(4):757-60.
PMID: 17849472
PMC: 2975705.
DOI: 10.1002/pbc.21330.
Leukemias and lymphomas: treatment and prophylaxis of the central nervous system.
Franklin J, Finlay J
Curr Treat Options Neurol. 2006; 8(4):335-45.
PMID: 16942676
DOI: 10.1007/s11940-006-0023-9.
Embryonic tumours of the central nervous system.
Navajas Gutierrez A, Fernandez-Teijeiro Alvarez A
Clin Transl Oncol. 2005; 7(5):219-27.
PMID: 15960935
DOI: 10.1007/BF02712821.
Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis.
Fleischhack G, Jaehde U, Bode U
Clin Pharmacokinet. 2005; 44(1):1-31.
PMID: 15634030
DOI: 10.2165/00003088-200544010-00001.
Neoplastic meningitis.
Aparicio A, Chamberlain M
Curr Neurol Neurosci Rep. 2002; 2(3):225-35.
PMID: 11937001
DOI: 10.1007/s11910-002-0081-7.
Leptomeningeal Neoplasms.
Abrey L
Curr Treat Options Neurol. 2002; 4(2):147-156.
PMID: 11827647
DOI: 10.1007/s11940-002-0023-3.
Intrathecal chemotherapy with antineoplastic agents in children.
Ruggiero A, Conter V, Milani M, Biagi E, Lazzareschi I, Sparano P
Paediatr Drugs. 2001; 3(4):237-46.
PMID: 11354696
DOI: 10.2165/00128072-200103040-00001.
Intrathecal chemotherapy with MX2 for treating glioma dissemination in vivo.
Mizumatsu S, Matsumoto K, Ono Y, Tamiya T, Furuta T, Ohmoto T
J Neurooncol. 2000; 49(1):41-7.
PMID: 11131985
DOI: 10.1023/a:1006436911670.
Neoplastic meningitis: diagnosis and treatment considerations.
Blaney S, Poplack D
Med Oncol. 2000; 17(3):151-62.
PMID: 10962524
DOI: 10.1007/BF02780522.
